164 related articles for article (PubMed ID: 11419173)
1. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI.
Alamo L; Fischer U
Eur Radiol; 2001; 11(6):970-7. PubMed ID: 11419173
[TBL] [Abstract][Full Text] [Related]
2. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities.
Weind KL; Maier CF; Rutt BK; Moussa M
Radiology; 1998 Aug; 208(2):477-83. PubMed ID: 9680579
[TBL] [Abstract][Full Text] [Related]
3. The use of breast ultrasound color Doppler vascular pattern morphology improves diagnostic sensitivity with minimal change in specificity.
Svensson WE; Pandian AJ; Hashimoto H
Ultraschall Med; 2010 Oct; 31(5):466-74. PubMed ID: 20094978
[TBL] [Abstract][Full Text] [Related]
4. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.
Huber S; Helbich T; Kettenbach J; Dock W; Zuna I; Delorme S
Radiology; 1998 Aug; 208(2):485-9. PubMed ID: 9680580
[TBL] [Abstract][Full Text] [Related]
5. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves].
Menna S; Di Virgilio MR; Burke P
Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI.
Wang S; Delproposto Z; Wang H; Ding X; Ji C; Wang B; Xu M
PLoS One; 2013; 8(7):e67731. PubMed ID: 23844077
[TBL] [Abstract][Full Text] [Related]
7. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results.
Jung EM; Jungius KP; Rupp N; Gallegos M; Ritter G; Lenhart M; Clevert DA; Kubale R
Clin Hemorheol Microcirc; 2005; 33(2):109-20. PubMed ID: 16151258
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography].
Knopp MV; Himmelhan N; Radeleff J; Junkermann H; Hess T; Sinn HP; Brix G
Radiologe; 2002 Apr; 42(4):280-90. PubMed ID: 12063736
[TBL] [Abstract][Full Text] [Related]
9. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions.
Ntziachristos V; Yodh AG; Schnall MD; Chance B
Neoplasia; 2002; 4(4):347-54. PubMed ID: 12082551
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
Schedel H; Oellinger H; Kohlschein P; Siewert C; Hadijuana J; Blohmer JU; Kissner T; Felix R
Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status].
Huber S; Delorme S; Zuna I
Radiologe; 1998 May; 38(5):390-3. PubMed ID: 9646345
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
13. [Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers].
Aichinger U; Schulz-Wendtland R; Krämer S; Lell M; Bautz W
Rofo; 2002 Nov; 174(11):1395-401. PubMed ID: 12424666
[TBL] [Abstract][Full Text] [Related]
14. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging.
Kvistad KA; Lundgren S; Fjøsne HE; Smenes E; Smethurst HB; Haraldseth O
Acta Radiol; 1999 Jan; 40(1):45-51. PubMed ID: 9973902
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
16. Videodensitometry in the examination of focal breast lesions after injection of an ultrasound contrast agent.
Blohmer JU; Reinhardt M; Schmalisch G; Lichtenegger W; Hausschild M; Kümmel S; Fischer T; Ohlinger R; Thomas A
Anticancer Res; 2006; 26(2C):1691-8. PubMed ID: 16617563
[TBL] [Abstract][Full Text] [Related]
17. [What is the role of Doppler color sonography associated with echo-signal enhancing levovist in complementary breast diagnosis?].
Grüner C; Schönwälder A; Schulz-Wendtland R; Lang N; Bautz W
Aktuelle Radiol; 1998 Mar; 8(2):58-62. PubMed ID: 9592578
[TBL] [Abstract][Full Text] [Related]
18. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
19. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
20. D-galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions.
Schroeder RJ; Maeurer J; Vogl TJ; Hidajat N; Hadijuana J; Venz S; Weber S; Felix R
Invest Radiol; 1999 Feb; 34(2):109-15. PubMed ID: 9951790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
